Alterations of G1‐S checkpoint in chordoma
Open Access
- 2 August 2005
- Vol. 104 (6), 1255-1263
- https://doi.org/10.1002/cncr.21296
Abstract
BACKGROUND To the authors' knowledge, little is known regarding the alterations of G1‐S checkpoint and their significance in chordoma, a rare bone tumor. The authors investigated the clinicopathologic relevance of cell cycle abnormalities in chordoma. METHODS The expression levels of p53, murine double minute 2 (MDM2), retinoblastoma protein (pRb), cyclin D1, p16INK4a, and p27Kip1 were investigated using immunohistochemical techniques; p53 mutations were studied by polymerase chain reaction (PCR)‐single‐strand conformation polymorphism, and mdm2 amplification was analyzed using real‐time quantitative PCR. The results were compared with clinicopathologic parameters in 101 lesions. RESULTS Approximately 10–45% of primary tumors presented alterations of p53, MDM2, cyclin D1, and pRb proteins; most tumors lacked expression of p16INK4a and p27Kip1. Alterations of p53, MDM2, cyclin D1, and pRb proteins were found to have cooperative effects on both higher proliferative ability (MIB‐1 labeling index [LI]) and increased nuclear pleomorphism, a previously described prognostic indicator for patients with chordoma. Multivariate analyses revealed that, among these alterations, p53 overexpression was the only independent factor for higher MIB‐1 LI. At the genetic level, mdm2 gene amplification was detected in 15.4% of the lesions but did not correlate with MDM2 overexpression or other clinicopathologic parameters. No p53 mutations were detected in the current series. Survival analysis revealed that p53 overexpression, but no other cell cycle alterations, was associated with a reduced overall survival. CONCLUSIONS Accumulation of cell cycle alterations led to an increased MIB‐1 LI and nuclear pleomorphism, a previously described prognostic indicator in chordoma. The authors believe that p53 overexpression in particular is associated with an unfavorable prognosis in patients with chordoma. Cancer 2005. © 2005 American Cancer Society.Keywords
This publication has 25 references indexed in Scilit:
- Skull base and nonskull base chordomasCancer, 2003
- Chordoma of the skull base: predictors of tumor recurrenceJournal of Neurosurgery, 2003
- Loss of p19ARF enhances the defects of Mdm2 overexpression in the mammary glandOncogene, 2002
- Association of p19ARF with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53The EMBO Journal, 1999
- Colonic retinoblastoma protein and proliferation in cancer and non-cancer patients#Journal of Gastroenterology and Hepatology, 1997
- Improved detection of P53 mutations in soft tissue tumors using new gel composition for automated nonradioactive analysis of single-strand conformation polymorphismElectrophoresis, 1997
- Cancer Cell CyclesScience, 1996
- Altered Patterns of MDM2 and TP53 Expression in Human Bladder CancerJNCI Journal of the National Cancer Institute, 1994
- A genetic model for colorectal tumorigenesisCell, 1990
- Silver staining of DNA in polyacrylamide gels: Linearity and effect of fragment sizeElectrophoresis, 1982